Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
Le Lézard14h
Sharon AI to Forge Australia's AI Future with Groundbreaking GPUaaS Supercomputer Featuring NVIDIA Accelerated Computing and Software
Sharon AI, Inc. ("Sharon AI"), a High-Performance Computing ("HPC") business focused on Artificial Intelligence ("AI"), Cloud GPU Compute Infrastructure and Data Storage, which recently announced ...